Hospital
Northwest Miss Regional Medical Center
Northwest Miss Regional Medical Center was paid $1.14M by Medicaid between Feb 2024 and Dec 2024, across 89 billing codes. Its largest line is 99284, emergency room visit (serious) — 31% of everything it billed.
33Billing provider infoNORTHWEST MISS REGIONAL MEDICAL CENTER
CLARKSDALE, MS 38614
CLARKSDALE, MS 38614
33aNPI1275217606assigned 06/14/2023
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.14M
24GClaims23,507
24DCodes billed89
24AFirst – last monthFeb 2024 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Mississippi
Rank by total paid#49 of 77
Median peer was paid$8.23M
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2024incomplete | 23,507 | $1.14M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 31% | 1,532 | 1,383 | $349K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 18% | 642 | 590 | $206K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 997 | 932 | $151K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.2% | 915 | 815 | $48K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.0% | 410 | 354 | $45K |
| G0378 | Hospital observation service, per hour | 3.8% | 315 | 232 | $43K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.6% | 272 | 252 | $29K |
| 71045 | Radiologic examination, chest; single view | 2.2% | 514 | 485 | $25K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.7% | 341 | 258 | $19K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.5% | 730 | 697 | $17K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 679 | 654 | $15K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.3% | 270 | 253 | $15K |
77 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | 1.2% | 363 | $14K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.1% | 146 | $13K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.1% | 409 | $12K |
| 80053 | Comprehensive metabolic panel | <1% | 1,656 | $10K |
| 86900 | <1% | 181 | $10K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 208 | $9K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 125 | $9K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 187 | $8K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,334 | $7K |
| 59025 | Fetal non-stress test | <1% | 111 | $7K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 53 | $6K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,044 | $5K |
| 83880 | <1% | 223 | $5K | |
| 87430 | <1% | 385 | $5K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 57 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 108 | $4K |
| 80306 | <1% | 360 | $4K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 33 | $4K |
| 85027 | <1% | 879 | $3K | |
| 86901 | <1% | 181 | $3K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 72 | $3K |
| 84484 | <1% | 306 | $3K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 16 | $3K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 50 | $2K |
| 83735 | <1% | 496 | $2K | |
| 87420 | <1% | 182 | $2K | |
| 81001 | <1% | 887 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 34 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 86 | $2K |
| 84703 | <1% | 314 | $2K | |
| 82731 | <1% | 48 | $1K | |
| 86850 | <1% | 51 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 123 | $1K |
| 83690 | <1% | 243 | $1K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 100 | $1K |
| 85730 | <1% | 246 | $828.16 | |
| 87040 | <1% | 118 | $797.17 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 192 | $783.52 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 152 | $648.43 |
| 82962 | <1% | 229 | $621.96 | |
| 85610 | <1% | 262 | $614.39 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 122 | $605.08 |
| 76830 | Ultrasound, transvaginal | <1% | 14 | $467.99 |
| 87210 | <1% | 164 | $467.67 | |
| 83605 | <1% | 60 | $465.46 | |
| 81025 | <1% | 62 | $451.58 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 13 | $403.73 |
| 81003 | <1% | 333 | $363.84 | |
| 84702 | <1% | 44 | $271.27 | |
| 82607 | <1% | 28 | $225.21 | |
| 82570 | <1% | 80 | $179.77 | |
| 84156 | <1% | 87 | $140.58 | |
| 86140 | <1% | 44 | $133.11 | |
| 80061 | Lipid panel | <1% | 12 | $108.71 |
| 85384 | <1% | 27 | $65.67 | |
| 85651 | <1% | 18 | $28.90 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 521 | $16.52 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 455 | $15.84 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 285 | $9.54 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 242 | $2.60 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 82 | $2.46 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 88 | $2.32 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 336 | $0.36 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 75 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 15 | $0.00 |
| 99238 | Hospital discharge day management, 30 minutes or less | 0% | 14 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 32 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 12 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 42 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 96 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 15 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 25 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 62 | $0.00 |
| 96376 | 0% | 14 | $0.00 | |
| 94660 | 0% | 72 | $0.00 | |
| G0379 | Direct admission of patient for hospital observation care | 0% | 31 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTILL, LORIE (CEO)